← Scroll for more →
Financial Statements — EVOXW
Balance Sheet
(in millions USD)| Metric | Q2 2026 | Q1 2026 | Q4 2025 |
|---|---|---|---|
| Cash & Equivalents | 0.84 | 1.01 | 1.12 |
| Total Current Assets | 0.96 | 1.15 | 1.21 |
| Total Non-current Assets* | 245.51 | 243.37 | 241.27 |
| Total Assets | 246.47 | 244.52 | 242.47 |
| Accounts Payable | 0.16 | 0.14 | 0.07 |
| Total Current Liabilities | 0.27 | 0.26 | 0.17 |
| Total Non-current Liabilities* | 9.60 | 9.60 | 9.60 |
| Total Liabilities | 9.87 | 9.86 | 9.77 |
| Retained Earnings | (8.89) | (8.67) | (8.50) |
| Total Stockholder Equity | (8.89) | (8.67) | (8.50) |
← Scroll for more columns →
* Derived from reported values
Income Statement
(in millions USD) (except per-share rows)| Metric | Q2 2026 | Q1 2026 |
|---|---|---|
| Selling, General & Admin | 0.22 | 0.17 |
| Operating Income | (0.22) | (0.17) |
| Net Income | 1.94 | 1.95 |
| Basic EPS | (0.01) | -- |
| Diluted EPS | (0.01) | -- |
← Scroll for more columns →
Cash Flow Statement
(in thousands USD)| Metric | Q2 2026 | Q1 2026 |
|---|---|---|
| Operating Cash Flow | (144.87) | (109.83) |
| Financing Cash Flow | (23.42) | -- |
← Scroll for more columns →